Deferred Tax Assets, Valuation Allowance of SOLENO THERAPEUTICS INC from 31 Dec 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
SOLENO THERAPEUTICS INC quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2025.
  • SOLENO THERAPEUTICS INC Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $79,905,000, a 4.3% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

SOLENO THERAPEUTICS INC Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $79,905,000 -$3,601,000 -4.3% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q4 2024 $83,506,000 +$17,550,000 +27% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q4 2023 $65,956,000 +$8,939,000 +16% 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q4 2022 $57,017,000 +$5,702,000 +11% 31 Dec 2022 10-K 25 Feb 2026 2025 FY
Q4 2021 $51,315,000 +$8,711,000 +20% 31 Dec 2021 10-K 22 Mar 2023 2022 FY
Q4 2020 $42,604,000 +$8,230,000 +24% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q4 2019 $34,374,000 +$6,696,000 +24% 31 Dec 2019 10-K 03 Mar 2021 2020 FY
Q4 2018 $27,678,000 +$4,145,000 +18% 31 Dec 2018 10-K 04 Mar 2020 2019 FY
Q4 2017 $23,533,000 -$8,484,895 -26% 31 Dec 2017 10-K 20 Mar 2019 2018 FY
Q4 2016 $32,017,895 +$4,238,870 +15% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $27,779,025 +$4,199,153 +18% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q4 2014 $23,579,872 +$1,578,347 +7.2% 31 Dec 2014 10-K 25 Mar 2016 2015 FY
Q4 2013 $22,001,525 31 Dec 2013 10-K 13 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.